“…In order to identify the occurrence of CR in HM patients and to understand its epidemiology, we reviewed series and selected case reports that report colonization or infection of HM patients with CR bacteria. These studies were undertaken in different areas of the world, including New York, New Delhi, China, Stockholm, Frankfurt, Roma, Brescia, Athens, Ankara, Cairo, and Haifa in the series studies (Tables 1−3; Cattaneo et al, 2012Cattaneo et al, , 2018Kjellander et al, 2012;Schelenz et al, 2013;Satlin et al, 2013aSatlin et al, , 2016El-Mahallawy et al, 2014;Trecarichi et al, 2015Trecarichi et al, , 2016Wang et al, 2015Wang et al, , 2017Micozzi et al, 2017;Ballo et al, 2019), and in United States, Brazil, Spain, Italy, Poland, Turkey, Israel, Japan, China, and Austria in the case reports (Table 4; Muchtar et al, 2012;Carattoli et al, 2013;Chang et al, 2013;Satlin et al, 2013b;Girmenia et al, 2015;Huang et al, 2015;Kara Leitner et al, 2015;Xing et al, 2015;Kantarcioglu et al, 2016;Tofas et al, 2016;Zhang et al, 2016Zhang et al, , 2018Majewski et al, 2017;Piedra-Carrasco et al, 2017;Asai et al, 2018). When we geolocate the regions that have reported the presence of CR bacteria in HM patients in Figure 1, it can be observed that all these studies have been reported in regions that are either endemic or have a significant increase in carbapenemase enzymes (a coincidence with regions with high levels of CR bacteria) (Figure 1).…”